2020 Update on CDK4/6 Inhibitors in BC: FDA-Approved Practice Changing Palbociclib, Ribociclib & Abemaciclib - What Are the Differences in Dosing, ORR & AE?

October 29, 2020

In this activity, breast cancer experts Joyce O’Shaughnessy, MD, and Sara M. Tolaney, MD, MPH, ...
read more ↘
Login to view comments. Click here to Login